Home
Programme
Agenda
Keynote speakers
B2B Meetings
FAQ
Participants
My agenda
Practical details
Venue
Accommodation
Register now
Edition 2023
Funding pathways from research to commercialisation
Upcoming
Sessions
Discover all sessions related to this theme and don't miss any interesting session for you.
Related sessions
May 15, 2024
9:05 AM
9:15 AM
Promoting trustworthy AI in healthcare in Europe – European Commission initiatives
HW
Hannah-Marie
Weller
Unit H3, DG CONNECT, European Commission
Policy Officer
May 15, 2024
11:15 AM
12:05 PM
Round table I Funding opportunities for digital health technologies: What funding instruments for each stage of development?
CB-M
Carole
Brückler - MODERATOR
Luxembourg Ministry of Economy
Head of Digital Health Technologies
GD
Guilhem
Davezac
SNCI
Economic Attaché
HE
Hayley
Every
EIT Health Belgium-Netherlands
Entrepreneurship Lead
NL
Natacha
Lemaire
French Ministry of Health
Rapporteur General
BM
Bert-Arjan
Millenaar
NLC Health Ventures
Founder & CEO
FR
Fabienne
Roussel
Vesalius Biocapital IV Partners
Partner
Related sessions
All
Speakers
CB-M
Carole
Brückler - MODERATOR
Luxembourg Ministry of Economy
Head of Digital Health Technologies
https://www.linkedin.com/in/carole-bruckler/
BM
Bert-Arjan
Millenaar
NLC Health Ventures
Founder & CEO
Bert-Arjan Millenaar is the founder and CEO of NLC Health Ventures, Europe’s leading early-stage healthtech investor and the world's largest healthcare venture builder. He brings over eighteen years of experience in business development and growth strategies at KPN and Scarlet, and as a partner of DTG, advising management boards of companies such as Euronext, Toyota, eBay, and Amsterdam RAI on...
linkedin.com/in/bamillenaar
FR
Fabienne
Roussel
Vesalius Biocapital IV Partners
Partner
Dr. Fabienne Roussel is an experienced healthcare specialist with more than 20 years of experience in managing innovation in life sciences. She joins Vesalius Biocapital IV as Partner, having served as an Analyst for VBC III. Prior to this, she held Technology Transfer positions at several research institutions in Belgium and Luxembourg, where she designed the innovation management strategy,...
https://www.linkedin.com/company/vesalius-biocapital-iv/?viewAsMember=true
GD
Guilhem
Davezac
SNCI
Economic Attaché
Guilhem Davezac serves as an Economic Attaché in the Equity Department at the Société Nationale de Crédit et d'Investissement (SNCI). With prior experience at a Big 4 firm and in a sustainability startup, he is part of the equity team responsible for managing SNCI’s stakes in companies and investment funds that support the development and diversification of Luxembourg's economy in the framework...
https://www.linkedin.com/in/guilhem-davezac/?originalSubdomain=lu
Luxinnovation offers expert and personalised support for all your innovation activities. Discover the services we provide for companies, research organisations and innovative start-ups.
Privacy Policy
Get in Touch
Contact us
Sign up now to our Newsletter
Need help using the plateform?
Contact us
Sign up now to our Newsletter
Need help using the plateform?
Powered by
Loading
